SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

IMA

ImageneBio, Inc.
NASDAQHealth Care

Latest close: 4.01 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 5, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  2. Aug 5, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Jul 23, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record30722 flagged findings
Reported transactions (Form 4)67since Aug 4, 2023 · and 2 other holdings
Corporate events (8-K)30since Feb 21, 2024

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as IKNA.

Reverse splits in 5 years

1 reverse split in 5 years (1:12 on Jul 28, 2025) · 1:12 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 307)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · BVF PARTNERS L P/IL · 9.9% · event on Jun 30, 26 · amendment
  • Aug 5, 26S-3 ↗Securities offering
  • Aug 5, 26POS AM ↗Securities offering
  • Aug 5, 26424B3 ↗Securities offering
  • Aug 5, 26S-3 ↗Securities offering
  • Aug 5, 2610-Q ↗Quarterly report
  • Aug 5, 268-K ↗Current report · Results
  • Jul 28, 26Form 3 ↗Insider transaction
  • Jul 28, 26Form 4 ↗Insider transaction
  • Jul 23, 26424B3 ↗Securities offering
  • Jul 23, 268-K ↗Current report · A senior executive left or was appointed
  • Jul 20, 26Form 4 ↗Insider transaction
  • Jun 29, 26424B3 ↗Securities offering
  • Jun 26, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Jun 17, 26424B3 ↗Securities offering
  • Jun 17, 268-K ↗Current report · A senior executive left or was appointed
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · BVF PARTNERS L P/IL · 9.9% · event on Mar 31, 26 · amendment
  • May 14, 26SCHEDULE 13G/A ↗Passive stake · Blue Owl Capital Holdings LP · 8.5% · event on Mar 31, 26 · amendment
  • May 8, 26424B3 ↗Securities offering

307 filings on record, the oldest from Feb 8, 21.

Listing the 25 most recent filings of the 307 on record.

8-Ks, explained

Stress3Structure14Governance26
  • Governance3 senior executive changes2026show all 3hide
    • Jul 23, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jun 26, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 17, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 13, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance4 senior executive changes2025 – 2026show all 4hide
    • Mar 17, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Feb 17, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Dec 18, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Nov 5, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Oct 29, 25StructureA material agreement was terminated+1 more in the same filing8-K 1.02 ↗
  • Oct 22, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Oct 10, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 12, 25StructureCompleted an acquisition or disposal+1 more in the same filing8-K/A 2.01 ↗
  • Aug 5, 25GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Aug 1, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jul 29, 25StructureEntered a material agreement+9 more in the same filing8-K 1.01 ↗
  • Jul 16, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jul 15, 25GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗

4 older filings not shown · The record reaches back to Mar 30, 21.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • May 28, 24StressRestructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
  • Jan 18, 24StressRestructuring plan with committed costs+4 more in the same filing8-K 2.05 ↗
  • Jun 30, 23StressListing notice (8-K 3.01)8-K 3.01 ↗

The full record holds 3 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • ORBIMED ADVISORS LLC13.1%Apr 14, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Leonard Braden Michael8.5%Jun 16, 25SCHEDULE 13D ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Omega Fund VI, L.P.8.4%Apr 14, 26SCHEDULE 13D ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
  • Atlas Venture Fund X, L.P.2.1%Jul 25, 25SCHEDULE 13D/A ↗9 co-filers on this document — the figure is the largest single stake, not their sum.
  • BML Investment Partners, L.P.1.9%Jul 25, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • BVF PARTNERS L P/IL9.9%Jun 30, 26SCHEDULE 13G/A ↗10 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • Trails Edge Capital Partners, LP9.9%Apr 14, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Blue Owl Capital Holdings LP8.5%Mar 31, 26SCHEDULE 13G/A ↗2 earlier filings
  • Deep Track Capital, LP7.9%Jul 28, 25SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Leonard Braden Michael7.6%Dec 31, 24SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
show 2 more holdershide
  • Funicular Funds, LP5.8%Dec 29, 25SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • GILEAD SCIENCES INC3.6%Dec 31, 24SCHEDULE 13G/A ↗

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jul 17, 26Sell$8KRobert B LallyPrincipal Accounting Officer↗
  • Jul 16, 26Sell$9KRobert B LallyPrincipal Accounting Officer↗
  • Dec 24, 25Buy$96KJOSEPH P SLATTERY↗
  • Jul 25, 25Buy$8.0MOtello Stampacchia↗
  • Jul 25, 25Buy$2.5MDavid P Bonita↗
Stock compensation, tax and giftsshow the 22 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 14, 26Compensationamount n/aKristin YaremaChief Executive Officer↗
  • Aug 14, 26Compensationamount n/aYanina Grant-HuertaChief Financial Officer↗
  • Aug 14, 26Compensationamount n/aYanina Grant-HuertaChief Financial Officer↗
  • Jul 25, 26Compensationamount n/aKristin YaremaChief Executive Officer↗
  • Jul 25, 26Otheramount n/aKristin YaremaChief Executive Officer↗
  • Mar 16, 26Compensationamount n/aKristin YaremaChief Executive Officer↗
  • Dec 30, 25Compensationamount n/aErin ButlerPrincipal Accounting Officer↗
  • Jul 28, 25Compensationamount n/aJotin MarangoChief Financial Officer↗
  • Jul 28, 25Tax$79KJotin MarangoChief Financial Officer↗
  • Jul 25, 25Compensationamount n/aErin ButlerPrincipal Accounting Officer↗
  • Jul 25, 25Compensation$208KORBIMED ADVISORS LLC↗
  • Jul 25, 25Compensationamount n/aOtello Stampacchia↗
  • Jul 25, 25Compensationamount n/aDavid P Bonita↗
  • Jul 25, 25Compensationamount n/aJonathan Jian Wang↗
  • Jul 25, 25Compensationamount n/aJonathan Jian Wang↗
  • Jul 25, 25Compensationamount n/aStephen Hui Wang↗
  • Jul 25, 25Compensationamount n/aStephen Hui Wang↗
  • Jul 25, 25Compensationamount n/aStephen Hui Wang↗
  • Aug 4, 23Compensationamount n/aDavid P Bonita↗
  • Aug 4, 23Compensationamount n/aORBIMED ADVISORS LLC↗
  • Aug 4, 23Compensationamount n/aDavid P Bonita↗
  • Aug 4, 23Compensationamount n/aORBIMED ADVISORS LLC↗

The full record holds 27 transactions and goes back to Jan 3, 23.

Its sector and its market

ImageneBio, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From ImageneBio, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow ImageneBio, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
307 documents on file, from Feb 8, 2021 to Aug 17, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.